⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Crizotinib Continuation Clinical Study

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Crizotinib Continuation Clinical Study

Official Title: CRIZOTINIB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED CRIZOTINIB CLINICAL STUDIES

Study ID: NCT05160922

Conditions

NSCLC
ALCL
IMT

Interventions

crizotinib

Study Description

Brief Summary: The purpose of this continuation study is to provide continued access to crizotinib treatment for eligible participants from a current Pfizer sponsored crizotinib clinical study that is planned to close.

Detailed Description: Participants not previously enrolled or who have discontinued study treatment or safety follow-up in a current Pfizer sponsored crizotinib clinical study are not eligible for participation in this continuation study.

Eligibility

Minimum Age: 1 Year

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing, China

Beijing Cancer Hospital, Beijing, Beijing, China

Fujian Province Oncology Hospital, Fuzhou, Fujian, China

Sun Yat-Sen University Cancer center, Guangzhou, Guandong, China

The First Affiliated Hospital of Guangzhou Medical University., Guang Zhou, Guangdong, China

Sun Yat-Sen University Cancer center, Guangzhou, Guangdong, China

Sun Yat-Sen University Cancer center, Guangzhou, Guangdong, China

Jilin Cancer Hospital, Changchun, Jilin, China

West China Hospital of Sichuan University, Wuhou District,Chengdu, Sichuan, China

The First Affiliated Hospital of College of Medicine,Zhejiang University, Hangzhou, Zhejiang, China

The First Affiliated Hospital of Guangzhou Medical University., Guangzhou, , China

Shanghai Chest Hospital, Shanghai, , China

ASST Monza, Monza, MB, Italy

National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan

Limited Liability Company "EuroCityClinic", Saint-Petersburg, , Russian Federation

National Taiwan University Hospital, Taipei, , Taiwan

Contact Details

Name: Pfizer CT.gov Call Center

Affiliation: Pfizer

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: